LLY

811.14

+0.38%↑

JNJ

156.56

+0.93%↑

ABBV

192.22

+0.51%↑

NVO

81.08

+3.14%↑

UNH

318.1

+2.45%↑

LLY

811.14

+0.38%↑

JNJ

156.56

+0.93%↑

ABBV

192.22

+0.51%↑

NVO

81.08

+3.14%↑

UNH

318.1

+2.45%↑

LLY

811.14

+0.38%↑

JNJ

156.56

+0.93%↑

ABBV

192.22

+0.51%↑

NVO

81.08

+3.14%↑

UNH

318.1

+2.45%↑

LLY

811.14

+0.38%↑

JNJ

156.56

+0.93%↑

ABBV

192.22

+0.51%↑

NVO

81.08

+3.14%↑

UNH

318.1

+2.45%↑

LLY

811.14

+0.38%↑

JNJ

156.56

+0.93%↑

ABBV

192.22

+0.51%↑

NVO

81.08

+3.14%↑

UNH

318.1

+2.45%↑

Search

Clearside Biomedical Inc

Closed

0.79

Overview

Share price change

24h

Current

Min

0.77

Max

0.8

Key metrics

By Trading Economics

Income

-917K

-8.2M

Sales

2M

2.3M

EPS

-0.11

Profit margin

-352.918

Employees

32

EBITDA

-102K

-4.8M

Recommendations

By TipRanks

Recommendations

Strong Buy

12 Months Forecast

+566.67% upside

Dividends

By Dow Jones

Next Earnings

11 sie 2025

Market Stats

By TradingEconomics

Market Cap

-9.7M

59M

Previous open

0.79

Previous close

0.79

Technical Score

By Trading Central

Confidence

Neutral Evidence

Clearside Biomedical Inc Chart

Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.

Related News

12 cze 2025, 20:41 UTC

Earnings

Adobe Raises Outlook After 2Q Sales Beat

12 cze 2025, 23:50 UTC

Earnings

Adobe Keeps Pivoting as AI Transforms Customer Needs -- Update

12 cze 2025, 23:50 UTC

Earnings

Adobe Customer Demand Shifting Toward Idea Generation, CFO Says

12 cze 2025, 23:50 UTC

Earnings

Adobe FireFly Products Drove Revenue Beat in 2Q, CFO Says

12 cze 2025, 23:48 UTC

Market Talk

Gold Steady Amid Geopolitical Risks -- Market Talk

12 cze 2025, 23:45 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

12 cze 2025, 23:45 UTC

Market Talk

Nikkei May Trade Rangebound Amid Tariff Uncertainty -- Market Talk

12 cze 2025, 21:26 UTC

Earnings

Friedman Industries 4Q Sales $129.2M >FRD

12 cze 2025, 21:25 UTC

Earnings

Friedman Industries 4Q EPS 76c >FRD

12 cze 2025, 21:11 UTC

Earnings

Adobe Beat Estimates and Raises Revenue Guidance -- Barrons.com

12 cze 2025, 20:50 UTC

Market Talk
Earnings

Tech, Media & Telecom Roundup: Market Talk

12 cze 2025, 20:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

12 cze 2025, 20:31 UTC

Earnings

Adobe Beat Estimates and Raises Revenue Guidance -- Barrons.com

12 cze 2025, 20:30 UTC

Earnings
Acquisitions, Mergers, Takeovers

Chime IPO: Stock Soars in Nasdaq Debut, Valuing It at Nearly $14 Billion -- Barrons.com

12 cze 2025, 20:15 UTC

Earnings

Adobe Sees FY25 Rev $23.5B-$23.6B >ADBE

12 cze 2025, 20:15 UTC

Earnings

Adobe Sees 3Q Rev $5.88B-$5.93B >ADBE

12 cze 2025, 20:14 UTC

Earnings

Adobe Stock Pops as Earnings Beat Estimates -- Barrons.com

12 cze 2025, 20:07 UTC

Earnings

Adobe Raises FY25 Rev and EPS Targets

12 cze 2025, 20:05 UTC

Earnings

Adobe Sees FY Adj EPS $20.50-Adj EPS $20.70 >ADBE

12 cze 2025, 20:05 UTC

Earnings

Adobe 2Q Digital Experience Revenue $1.46B >ADBE

12 cze 2025, 20:05 UTC

Earnings

Adobe 2Q Digital Media Revenue $4.35B >ADBE

12 cze 2025, 20:05 UTC

Earnings

Adobe Sees 3Q EPS $4.00-EPS $4.05 >ADBE

12 cze 2025, 20:05 UTC

Earnings

Adobe 2Q Net $1.69B >ADBE

12 cze 2025, 20:05 UTC

Earnings

Adobe 2Q EPS $3.94 >ADBE

12 cze 2025, 20:05 UTC

Earnings

Adobe 2Q Digital Experience Revenue Up 10% >ADBE

12 cze 2025, 20:05 UTC

Earnings

Adobe 2Q Rev $5.87B >ADBE

12 cze 2025, 20:05 UTC

Earnings

Adobe Sees 3Q Adj EPS $5.15-Adj EPS $5.20 >ADBE

12 cze 2025, 20:05 UTC

Earnings

Adobe Sees FY EPS $16.30-EPS $16.50 >ADBE

12 cze 2025, 20:05 UTC

Earnings

Adobe 2Q Digital Media Revenue Up 11% >ADBE

12 cze 2025, 20:05 UTC

Earnings

Adobe 2Q Adj EPS $5.06 >ADBE

Peer Comparison

Price change

Clearside Biomedical Inc Forecast

Price Target

By TipRanks

566.67% upside

12 Months Forecast

Average 5.4 USD  566.67%

High 8 USD

Low 3 USD

Based on 5 Wall Street analysts offering 12 month price targets forClearside Biomedical Inc - Dist in the last 3 months.

Rating Consensus

By TipRanks

Strong Buy

5 ratings

5

Buy

0

Hold

0

Sell

Technical Score

By Trading Central

0.8417 / 0.8939Support & Resistance

Short Term

Neutral Evidence

Intermediate Term

Strong Bearish Evidence

Long Term

Weak Bearish Evidence

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

About Clearside Biomedical Inc

Clearside Biomedical, Inc., a biopharmaceutical company, focuses on the revolutionizing the delivery of therapies to the back of the eye through the suprachoroidal space. It offers XIPERE, a triamcinolone acetonide suprachoroidal injectable suspension for the treatment of uveitis macular edema. It also develops CLS-AX, an axitinib injectable suspension for suprachoroidal injection, which is in Phase IIb clinical trial to treat wet AMD. The company has a collaboration with Bausch Health, Arctic Vision, REGENXBIO, Inc., BioCryst Pharmaceuticals, Inc., and Aura Biosciences. Clearside Biomedical, Inc. was incorporated in 2011 and is headquartered in Alpharetta, Georgia.